Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s ...

An Israeli study has found that patients taking the weekly jab - or similar drugs - were twice as likely to suffer from a ...

A new study found a link between GLP-1s and a higher risk of neovascular age-related macular degeneration, an eye disease ...

Called non-arteritic anterior ischemic optic neuropathy (NAION), the condition may affect up to 1 in 10,000 people taking semaglutide.

The European Medicines Agency's safety committee has concluded that a potentially dangerous eye condition is a very rare side effect of Novo Nordisk's popular treatments Ozempic and Wegovy, it said on ...

A new study brings into focus the relationship between diabetic GLP-1 users and the elevated risk of age-related eye disease.

GLP-1 drugs like Ozempic are associated with a higher risk of developing wet age-related macular degeneration in people with ...

The European Medicines Agency has identified a rare eye condition risk linked to Novo Nordisk’s semaglutide drugs.

Research shows a possible link between antidiabetic medicines Ozempic and Wegovy ... Picture: AFP Of the more than 40 complaints of eye disorders associated with semaglutide, 19 were made by ...